slides · global inventory
Callout
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 96,741
Current window 11,521-11,550
Pages 3,225
Rows per page 30
Component
11,521-11,550 of 96,741
01
This is a short-seller research note cover page/executive summary.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller Beat · Setup & Stakes2 hits
18
The slide uses a narrative of past professional failure and alleged fraud to undermine the credibility of the current CFO.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller Beat · The Monster2 hits
21
The slide uses EMA data to contradict the limited disclosure in the primary trial paper.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller Beat · The MonsterLoop · Aha Moment2 hits
25
The slide uses highly critical, adversarial language ('toxic drug', 'face-planted', 'questionable French lab') to frame the company negatively.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller Beat · The MonsterLoop · Aha Moment2 hits
36
The slide uses visual evidence (empty chair, press conference) to frame the subject as a villain in a political/regulatory context.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller Beat · The Struggle2 hits
39
The slide uses a 'short' thesis argument to frame scientific data as fraudulent.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller Beat · The Struggle2 hits
43
The slide uses a Q&A format to present qualitative evidence of internal doubt regarding clinical trial integrity.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller Beat · The Struggle2 hits
49
Includes a process diagram showing the progression from hERG block to Torsades de Pointes.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller Beat · The Struggle2 hits
53
The slide uses a historical precedent (Seldane/terfenadine recall) to frame the severity of a current drug's (pitolisant) safety profile, highlighting specific death and exposure statistics.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller Beat · The VictoryLoop · The Reveal2 hits
56
The slide uses a direct quote from scientific literature to establish a causal link between the drug's mechanism and its side effects.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller Beat · The VictoryLoop · The Reveal2 hits
57
The slide uses a specific research paper abstract to validate the claim of inherent cardiotoxicity.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller Beat · The VictoryLoop · The Reveal2 hits
65
The slide uses a 'before-after' or 'evidence-based' contradiction structure to undermine the value of the licensed asset.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller Beat · The Victory2 hits
70
The slide uses a 'villain' framing by highlighting the industry-wide failure of a specific drug class.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller Beat · The Victory2 hits
74
The slide uses a combination of narrative summary and a direct excerpt from a scientific review paper to validate the difficulty of the target.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 2 hits
79
The slide uses a forensic literature review approach to highlight historical concerns about the drug's safety profile (cardiotoxicity, bioavailability, etc.) that were allegedly ignored or suppressed.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 2 hits
80
The slide uses a primary text block to summarize the contradiction, followed by a direct excerpt from a 2008 paper as evidence.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 2 hits
96
The slide uses a Q&A format to discredit the competitor's R&D rigor.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 2 hits
105
The slide uses a 'quote-and-critique' structure to expose potential data manipulation in clinical reporting.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 2 hits
13
Uses a screenshot of a 2019 website archive to highlight the gap between marketing rhetoric and technical reality.IonQ Inc. (IONQ) · Scorpion Capital
Activist deck Short seller Beat · The Problem with IonQ's Technology2 hits
16
Uses a quote from Mikhail Dyakov to frame the entire industry as a 'Ponzi scheme'.IonQ Inc. (IONQ) · Scorpion Capital
Activist deck Short seller Beat · The Problem with IonQ's Technology2 hits
43
The slide uses screenshots of official cloud provider documentation to invalidate the company's public claims.IonQ Inc. (IONQ) · Scorpion Capital
Activist deck Short seller 2 hits
63
Uses red boxes to highlight marketing imagery and an arrow to point to the actual enclosure.IonQ Inc. (IONQ) · Scorpion Capital
Activist deck Short seller 2 hits
76
Uses direct quotes and a chart from an investor presentation to highlight a discrepancy in manufacturing capability claims.IonQ Inc. (IONQ) · Scorpion Capital
Activist deck Short seller 2 hits
103
Uses expert testimony to undermine the company's technical claims regarding fidelity.IonQ Inc. (IONQ) · Scorpion Capital
Activist deck Short seller 2 hits
108
Uses direct quotes from former employees to undermine the company's technical roadmap.IonQ Inc. (IONQ) · Scorpion Capital
Activist deck Short seller 2 hits
110
The slide uses a screenshot of an IEEE Spectrum article to provide external authority for the critique.IonQ Inc. (IONQ) · Scorpion Capital
Activist deck Short seller Loop · Iceberg2 hits
128
The slide uses a direct expert quote to undermine the company's technical viability.IonQ Inc. (IONQ) · Scorpion Capital
Activist deck Short seller 2 hits
152
The slide uses a direct quote from an earnings call transcript to expose a lack of transparency regarding revenue sources.IonQ Inc. (IONQ) · Scorpion Capital
Activist deck Short seller 2 hits
153
Uses external quotes from the Baltimore Sun and UMD's own website to frame the relationship as a conflict of interest.IonQ Inc. (IONQ) · Scorpion Capital
Activist deck Short seller 2 hits
172
The slide uses a 'villain' framing by questioning the capacity of the subject to fulfill all stated obligations.IonQ Inc. (IONQ) · Scorpion Capital
Activist deck Short seller 2 hits